Logo Logo
Help
Contact
Switch Language to German

Geissler, M.; Martens, U. M.; Knorrenschield, R.; Greeve, J.; Florschütz, A.; Tannapfel, A.; Wessendorf, S.; Seufferlein, T.; Kanzler, S.; Heinemann, V.; Held, S. and Reinacher-Schick, A. (2017): mFOLFOXIRI plus panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild-type metastatic colorectal cancer m(CRC): A randomized phase II VOLFI trial of the AIO (AIO-KRK0109). In: Annals of Oncology, Vol. 28

Full text not available from 'Open Access LMU'.

Actions (login required)

View Item View Item